Volume 32, Issue 216 (1-2023)
J Mazandaran Univ Med Sci 2023, 32(216): 105-114 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Gholamnejad S, Bahar A, Fazl Ali M. Effectiveness of Mindfulness-Based Cognitive Therapy on Life Expectancy, Fear of Death and Glycemic Control in Diabetic Patients with Depression. J Mazandaran Univ Med Sci 2023; 32 (216) :105-114
URL: http://jmums.mazums.ac.ir/article-1-16824-en.html
URL: http://jmums.mazums.ac.ir/article-1-16824-en.html
Abstract: (1134 Views)
Background and purpose: Depression is one of the most common psychiatric disorders in diabetic patients that could change the disease prognosis in addition to affecting the treatment path. The aim of this study was to evaluate the effectiveness of mindfulness-based cognitive therapy (MBCT) on life expectancy, fear of death, and glycemic control in diabetic patients suffering from depression.
Materials and methods: A quasi-experimental research with pre-test/post-test design and control group was conducted. The statistical population included 867 patients. The study inclusion criteria were type 2 diabetes, 20-65 years of age, secondary school education, and HbA1c below 7. Beck Depression Inventory-II (BDI-II) was completed and patients with moderate to severe depression were selected (n= 30). They were randomly assigned into two groups. Data were collected using Miller Hope Scale, Templer Death Anxiety Scale (1970), BDI-II, and measurement of HbA1c level. MBCT was performed for eight weekly sessions of 90 minutes, while the control group received no specific training. Data analysis was carried out applying Analysis of covariance (ANCOVA).
Results: Findings showed significant improvements in life expectancy (P= 0.000, F= 25.21), death anxiety (P= 0.000, F= 157.77), and HbA1c level (P= 0.000, F= 151.61) after the intervention.
Conclusion: MBCT is effective in improving life expectancy, fear of death, and HbA1c level in diabetic patients with depression. Therefore, attention should be paid to diagnose depressive disorders in diabetic patients and their follow-up and non-pharmacological treatments such as MBCT which could be of great benefit in controlling blood sugar level and reducing the severity of chronic complications.
Materials and methods: A quasi-experimental research with pre-test/post-test design and control group was conducted. The statistical population included 867 patients. The study inclusion criteria were type 2 diabetes, 20-65 years of age, secondary school education, and HbA1c below 7. Beck Depression Inventory-II (BDI-II) was completed and patients with moderate to severe depression were selected (n= 30). They were randomly assigned into two groups. Data were collected using Miller Hope Scale, Templer Death Anxiety Scale (1970), BDI-II, and measurement of HbA1c level. MBCT was performed for eight weekly sessions of 90 minutes, while the control group received no specific training. Data analysis was carried out applying Analysis of covariance (ANCOVA).
Results: Findings showed significant improvements in life expectancy (P= 0.000, F= 25.21), death anxiety (P= 0.000, F= 157.77), and HbA1c level (P= 0.000, F= 151.61) after the intervention.
Conclusion: MBCT is effective in improving life expectancy, fear of death, and HbA1c level in diabetic patients with depression. Therefore, attention should be paid to diagnose depressive disorders in diabetic patients and their follow-up and non-pharmacological treatments such as MBCT which could be of great benefit in controlling blood sugar level and reducing the severity of chronic complications.
Keywords: cognitive therapy, mindfulness, life expectancy, fear, glycemic control, diabetes, depression
Type of Study: Research(Original) |
Subject:
psychology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
